麦科田拟港股IPO获中国证监会接收材料

Group 1: Macotian - Macotian plans to conduct an IPO in Hong Kong and has received material acceptance from the China Securities Regulatory Commission for its full circulation application [1] - The company offers a comprehensive product portfolio that meets clinical needs across various healthcare settings, including hospitals and community health centers [1] - As of June 30, 2025, Macotian has commercialized over 50 life support products, 80 minimally invasive products, and 210 in vitro diagnostic products, with a presence in over 140 countries and regions [1] Group 2: Shengwei Times - Shengwei Times is a provider of urban ride-hailing services and intercity passenger transport information services in China, ranking 14th in the ride-hailing market by GTV in 2024 [2] - The company has undertaken digital passenger transport projects in 17 provinces, autonomous regions, and municipalities as of June 30, 2025 [2] - Shengwei Times collaborates with various passenger transport companies to offer customized services, establishing operations in over 30 provinces and regions [2] Group 3: Zhongrun Solar Energy - Zhongrun Solar Energy specializes in the manufacturing and sales of N-type and P-type photovoltaic cells, with vertical expansion into the photovoltaic module industry [3] - The company ranks second globally in photovoltaic cell manufacturing by external shipment volume, holding a market share of 14.6% for the year 2024 [3] - Zhongrun Solar Energy has a market share of 18.3% among specialized photovoltaic cell manufacturers, serving over 1,000 customers across more than 32 countries and regions [3]